---
title: "SLC22A1"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "# Analysis of Gene SLC22A1"
tags: ['SLC22A1', 'OrganicCationTransporter', 'DrugTransport', 'DrugResponse', 'Mutation', 'Metformin', 'HepatocellularCarcinoma', 'PolycysticOvarySyndrome']
---

# Analysis of Gene SLC22A1

## Gene Information

- SLC22A1 is also known as solute carrier family 22 member 1.
- Its location is on chromosome 6 (6q26.1).
- The gene has a strand orientation of plus strand and is composed of 9 exons.
- The Aliases for SLC22A1 include OCT1, and POT1.

## Function of gene

- The SLC22A1 gene encodes an organic cation transporter protein which is responsible for the transport of endogenous compounds like dopamine, histamine, and serotonin, as well as exogenous compounds like metformin, inorganic cations (e.g., tetraethylammonium), and many clinically used drugs (e.g., cimetidine, morphine, and vinblastine) from the plasma membrane of the cell. 

## External IDs and links

- HGNC ID: 10903 
- NCBI Entrez ID: 6580 
- Ensembl ID: ENSG00000118621 
- OMIM ID: 600622 
- UniProtKB/Swiss-Prot ID: O15244 

## AA mutation list and mutation types with dbSNP ID

| AA Mutation | Mutation Type | dbSNP ID |
| ----------- | ------------- | -------- |
| M15I        | missense      | rs12208357 |
| V408M       | missense      | rs59444578 |
| L447F       | missense      | rs72552741 |
| T460N       | missense      | rs7817756  |
| G465R       | missense      | rs35391527 |

## Somatic SNVs/InDels with dbSNP ID

| Mutation Type | dbSNP ID |
| ------------- | -------- |
| SNV           | rs2065982 |
| INDEL         | rs144158633 |

## Related Diseases

- Impaired uptake in liver and kidneys due to mutations in this gene can lead to underdosing of drugs such as metformin, leading to a poor therapeutic effect. 
- Hepatocellular carcinoma has also been associated with the SLC22A1 gene.

## Treatment and Prognosis

- A detailed treatment plan cannot be given for SLC22A1 as it is a gene responsible for drug transport, and its mutations can lead to variable effects on drug handling. 
- A prognosis also cannot be detailed as the effects of mutations are variable and context-specific.

## Drug Response

- The SLC22A1 gene is responsible for drug uptake and mutations in this gene may cause drug resistance or underdosing in certain drugs such as metformin.

## Related Papers

- Subject: SLC22A1 polymorphism and response to metformin in women with polycystic ovary syndrome 
    - Author: Fawzia A. Alghamdi 
    - DOI Link: 10.2147/DDDT.S106456  

- Subject: SLC22A1 rs622342, but not rs594709 nor rs628031 functional polymorphism determines impaired response and side effects to metformin in Caucasians with Type 2 diabetes mellitus 
    - Author: Valeria Costa 
    - DOI Link:  10.1111/j.1463-1326.2009.01164.x  

- Subject: Genetic Variations in Transporters Associated With Metformin Response in Patients With Type 2 Diabetes: A Systematic Review 
    - Author: Yan-Chao Wu 
    - DOI Link: 10.3389/fphar.2019.00104

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**